Advertisement

Treatment Action Group

Table of Contents

October 2003

Slice of Pie: Global Market Share for HIV Drugs
GSK	45%
BMS	23%
Abbott	13%
Advertisement Merck	5%
Pfizer	5%
BI, Gilead, Roche	9%
Source: IMS Health; Evaluate Pharma

Contents:

The Diabolic Science: VaxGen's Claims of Vaccine Efficacy Evanesce in Autumn's Last Light
By Richard Jefferys
Medi Gap: Congressional Juggling of Medicare Drug Coverage Leaves Many in the Lurch
Letter to President Bush
By William E. Arnold, Mark Harrington and A. Cornelius Baker

This article was provided by Treatment Action Group. It is a part of the publication TAGline.

My Health Tracker

Follow Us on Twitter

Widgets and RSS Feeds

U.S. ASO Finder

The First Man to Be Cured of AIDS: An Update on the Amazing Story -- This Month in HIV

OIs and Co-Infections and STIs -- Oh, My!

HIV Antiretrovirals in Development: An Update From ICAAC 2009

World AIDS Day 2009: Home

Back From the Brink: A Blog Entry by Thomas DeLorenzo

Advertisement

Our Mission and Team | Content Policy | Content Providers | Privacy Policy | Advertising and Sponsorship | Write to Us | Link to Us

The Body is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.